-
Induction of c-fos Gene Expression by Urokinase-Type Plasminogen Activator in Human Ovarian Cancer C
The ability to fractionate nucleic acids and to determine which of them has sequ
2025-03-18 39 -
Flow Cytometry for Non-Hodgkin and Classical Hodgkin Lymphoma
Multiparametric flow cytometry is a powerful diagnostic tool that permits rapid
2025-03-18 44 -
Antisense IGF-I for Hepatocellular Carcinoma
Antisense gene therapy involves the selective inhibition of expression or functi
2025-03-18 48 -
Purification of the Mitotic Checkpoint Complex, an Inhibitor of the APC/C From HeLa Cells
The mitotic checkpoint prevents cells with unaligned chromosomes from prematurel
2025-03-18 41 -
PPAR/ Agonist Increases the Expression of PGE2 Receptor Subtype EP4 in Human Lung Carcinoma Cells
Lung carcinoma remains one of the most common malignant tumors in the world desp
2025-03-18 39 -
Methods to Analyze the Effects of the Urokinase System on Cancer Cell Adhesion, Proliferation, Migra
For cellular-invasive processes during a variety of physio- and pathophysiologic
2025-03-18 40 -
Regulation of Angiostatin Mobilization by Tumor-Derived Matrix Metalloproteinase-2
In recent years, the observation that many endogenous angiogenesis inhibitors ar
2025-03-18 44 -
Intratumoral Gene Transfer of the HLA-B7 Gene Into Colon Carcinoma Metastases
Colorectal adenocarcinoma, with more than 150,000 new cases diagnosed in the Uni
2025-03-18 43 -
Identification of Tumor-Associated Antigens as Diagnostic and Predictive Biomarkers in Cancer
Many studies demonstrated that cancer sera contain antibodies which react with a
2025-03-18 54 -
Detection of Low Levels of DNA Fragmentation in Ovarian Tumor Cell Lines
The techniques presented in this chapter describe the experimental procedure for
2025-03-18 47 -
Polymerase Chain Reaction Based Methods for Assessing Chimerism Following Allogeneic Bone Marrow Tra
It is important to be able to assess the contribution of donor cells to the graf
2025-03-18 47 -
Genetic Modification of Cell Lines to Enhance Their Metastatic Capability
Metastasis is the final step in tumor progression from a benign cell to a fully
2025-03-18 56 -
Tumor Necrosis Factor as a Pharmacological Target
Tumor necrosis factor (TNF) was originally described as a molecule with antitumo
2025-03-18 48 -
Practical Methods for Tissue Microarray Construction
The tissue microarray (TMA) of Kononen et al. is an extension of an idea origina
2025-03-18 51 -
Quantitative, Competitive RT-PCR Analysis of Biomarkers in the Study of Neoplasia
The current status of the evaluation of many neoplasias (e.g., carcinoma of the
2025-03-18 152
